E
HOOKIPA Pharma Inc. HOOK
$0.825 -$0.0255-3.00%
Recommendation
Sell
Prev Close
$0.825
Volume
32,489
Avg Vol (90D)
103,270
Market Cap
$10.35M
Dividend & Yield
--
52-Week Range
$0.8151 - $10.50
P/E (TTM)
--
EPS (TTM)
-$3.52
My Lists My Alerts
Rating
Reward
E
Very Weak
Risk
D-
Weak
Rating Factors
Growth Index
Fair
Efficiency Index
Very Weak
Solvency Index
Good
Total Return Index
Very Weak
Volatility Index
Weak
Dividend Index
--
Headlines
HOOKIPA Pharma Inc. ( HOOKIPA ) Statement regarding potential combination for Poolbeg Pharma plc ( Poolbeg )
2/20/2025 - Globe Newswire
HOOKIPA Pharma Inc. ( HOOKIPA ) Statement regarding potential combination for Poolbeg Pharma plc ( Poolbeg )
2/20/2025 - Globe Newswire
EcoR1 Capital, LLC Reduces Stake in HOOKIPA Pharma Inc: Analyzing the Implications
2/14/2025 - GuruFocus
Hookipa Pharma announces enrollment completion of Phase 1b HB-500 trial
1/30/2025 - The Fly
HOOKIPA Pharma Announces Enrollment Completion of Phase 1b Clinical Trial Evaluating HB-500 for ...
1/30/2025 - GuruFocus
HOOKIPA Pharma Announces Enrollment Completion of Phase 1b Clinical Trial Evaluating HB-500 for the Treatment of HIV
1/30/2025 - Globe Newswire
Surprising Analyst 12-Month Target For DFAT
1/22/2025 - ETF Channel
Hookipa Pharma (HOOK) was downgraded to a Hold Rating at Citi
1/12/2025 - TipRanks Financial Blog
Hookipa Pharma downgraded to Neutral from Buy at H.C. Wainwright
1/10/2025 - TipRanks Financial Blog
Hookipa Pharma just downgraded at H.C. Wainwright, here's why
1/10/2025 - The Fly
Poolbeg Pharma plc ( Poolbeg ) and HOOKIPA Pharma Inc. ( HOOKIPA ) Update on Potential Combination of Poolbeg and HOOKIPA
1/10/2025 - Globe Newswire
HOOKIPA Pharma Inc - FORM 8 (OPD)
1/8/2025 - Globe Newswire
HOOKIPA Pharma Announces Notice to Shareholders Regarding U.K. Disclosure Requirements
1/7/2025 - GuruFocus
HOOKIPA Pharma Announces Notice to Shareholders Regarding U.K. Disclosure Requirements
1/7/2025 - Globe Newswire
Poolbeg Pharma plc ( Poolbeg ) and HOOKIPA Pharma Inc. ( HOOKIPA ) Update on Potential Combination of Poolbeg and HOOKIPA
1/7/2025 - Globe Newswire
HOOKIPA Pharma Inc. ( HOOKIPA ) Rule 2.9 Announcement Amendment
1/6/2025 - Globe Newswire
Hookipa Pharma to acquire Poolbeg Pharma
1/2/2025 - TipRanks Financial Blog
Hookipa Pharma to acquire Poolbeg Pharma
1/2/2025 - The Fly
Poolbeg Pharma plc ( Poolbeg or the Company ) Combination of Poolbeg and HOOKIPA Pharma Inc.
1/2/2025 - Globe Newswire
The Market Doesn't Like What It Sees From HOOKIPA Pharma Inc.'s (NASDAQ:HOOK) Revenues Yet As Shares Tumble 26%
12/21/2024 - Simply Wall St
Hookipa Pharma downgraded to Sector Perform from Outperform at RBC Capital
12/20/2024 - TipRanks Financial Blog
Hookipa Pharma just downgraded at RBC Capital, here's why
12/20/2024 - The Fly
Hookipa Pharma price target lowered to $7 from $24 at JMP Securities
11/21/2024 - TipRanks Financial Blog
Hookipa Pharma price target lowered by $17 at JMP Securities, here's why
11/21/2024 - The Fly
Hookipa Pharma announces workforce reduction of 80%, pause of eseba-vec program
11/21/2024 - The Fly
Income Statement
Total Revenue (TTM)
$43.95M
EBITDA (TTM)
-$42.03M
EBIT (TTM)
-$44.79M
Net Income (TTM)
-$43.50M
Balance Sheet
Total Assets (Q)
$82.55M
Total Debt (Q)
$875.00K
Total Liabilities (Q)
$31.33M
Book Value Per Share (Q)
$4.08
Cash Flow
Cash from Operations (TTM)
-$76.98M
Cash from Investing (TTM)
-$194.00K
Cash from Financing (TTM)
-$1.28M
Net Change in Cash (TTM)
-$77.64M
Filings
Filing Date
Friday, February 28, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Created with Highstock 5.0.142. Dec16. Dec30. Dec13. Jan27. Jan10. Feb24. Feb10. Mar24. Mar$0.00$1.00$2.00$3.00Price as of Apr 04, 2025
Beta
1.84
7-Day Total Return
-31.25%
30-Day Total Return
-53.12%
60-Day Total Return
-55.65%
90-Day Total Return
-61.63%
Year to Date Total Return
-57.69%
1-Year Total Return
-89.05%
2-Year Total Return
-88.33%
3-Year Total Return
-96.05%
5-Year Total Return
-99.01%
52-week Low
Apr 03, 2025 - $0.8151
52-week High
May 23, 2024 - $10.50
Valuation
Market Cap
$10.35M - Nano Cap
Enterprise Value
-$28.46M
Price/Sales (TTM)
0.24
Price/Book (Q)
0.20
Dividends and Shares
Shares Outstanding
12.54M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.hookipapharma.com
Phone Number
431 890 6360
Address
350 Fifth Avenue
72nd Floor - Suite 7240
New York, NY 10118
Country
United States
Year Founded
2011
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunetherapeutics targeting infectious diseases based on its proprietary arenavirus platform. The company’s... more
NASDAQ 04/04/2025 4:00PM Eastern Quotes delayed
Weiss Ratings